← Tickers

DNA

Ginkgo Bioworks · NYSE · USA

Cap tier
Small
Approx cap
$1.2B
Bull scenarios
28
Adverse scenarios
0
Other links
0
Modeled impact
unknown
0 explicit links; 28 public links lack move; 0 lack probability

Themes & clusters

From SRC_B Theme-Company Matrix
C10AI-discovered Drugs PipelineClustering models (for DNA synthesis delivery)Dark science factories (nature data mining)Environmental DNA (eDNA) sequencingPlastic-degrading microbial consortiumScrewworm gene drive (male-only progeny)

Investment thesis

From SRC_B Company Master

Synthetic biology foundry — closest thing to 'dark science factory' public play

Bull scenarios (28)

Predictions where this ticker benefits
PredRoleDomainPredictionPredictorCurrentMoveImpactStatus
245_011pure_playBiotech/LongevityColossal is spinning out a dozen companies each with massive potentialPeter Diamandis54.1%unknownunknownpending
245_005pure_playBiotech/LongevityCountries will become customers to preserve endangered species via ColossalPeter Diamandis52.9%unknownunknownpending
235_029pure_playBiotech/LongevityBig pharma companies will transition into longevity business in next 3 years.Peter Diamandis52.9%unknownunknownpending
235_027pure_playBiotech/LongevityLongevity VC market expected to grow from $8.5B in 2024 to $12-18B in 2026.Peter Diamandis46.5%unknownunknownpending
245_036pure_playBiotech/LongevityColossal will continue seeding and spinning out new companies from scientific discoveriesBen Lamm45.0%unknownunknownpending
245_041pure_playBiotech/LongevityColossal will build a living lab in UAE in addition to BiovaultBen Lamm45.0%unknownunknownpending
245_039pure_playBiotech/LongevityColossal has not yet started work on dinosaurs, corals, dragons or PokemonBen Lamm45.0%unknownunknownpending
245_007pure_playBiotech/LongevityColossal will bring back the woolly mammothBen Lamm44.9%unknownunknownpending
245_033pure_playBiotech/LongevityColossal will work to reintroduce all de-extincted species back into their environmentsBen Lamm44.3%unknownunknownpending
245_014pure_playBiotech/LongevityColossal has major announcements coming this year with a local government on productionizing cloning of endangered speciesBen Lamm41.3%unknownunknownpending
245_027pure_playBiotech/LongevityColossal DNA synthesis delivery will reach 20x the largest prior delivery by end of 2026Ben Lamm41.0%unknownunknownpending
245_006pure_playBiotech/LongevityColossal will productionize species development via biobanking, synthetic biology, automation, AI, computer vision and artificial wombsBen Lamm41.0%unknownunknownpending
239_031pure_playBiotech/LongevityBen Lamb / Colossal could engineer a Pikachu-like creatureBen Lamm40.6%unknownunknownpending
245_015pure_playBiotech/LongevityColossal could theoretically create Pikachu (engineer novel designer organisms)Ben Lamm40.6%unknownunknownpending
245_026pure_playBiotech/LongevityColossal editing tech will be applicable to human healthcare (spun out/licensed)Ben Lamm40.6%unknownunknownpending
245_029pure_playBiotech/LongevityIVF will be transformed by Colossal's hydrogel/microfluidics embryo tech and new grading scaleBen Lamm40.6%unknownunknownpending
245_045pure_playBiotech/LongevityColossal considers Colossal platform core will stay focused on biodiversity and de-extinctionBen Lamm39.4%unknownunknownpending
INF_027pure_playBiotech/LongevityAI infrastructure applied to structural biology will compress drug-development timelines from approximately a decade to weeks — potentially eradicating many major diseases within 10 years. Requires localized high-speed InfiniBand networking inside the DC.Demis Hassabis37.7%unknownunknownpending
233_015pure_playBiotech/LongevityInfinite longevity is coming for this generation of kids.Peter Diamandis37.6%unknownunknownpending
245_037pure_playBiotech/LongevityMosquito gene drive halted in Africa was possibly wrong to stop since mosquitoes are part of the food web (but invasives are not)Ben Lamm37.5%unknownunknownpending
IND_020pure_playBiotech/LongevityMassive 'rerating' of Biotech industry — by 2026, generative biology achieves its 'De Novo' moment where an AI-designed drug candidate triggers multi-billion-dollar partnerships; AI expands Total Addressable Market (TAM) of gene editing by 100x, moving...Morgan Stanley36.1%unknownunknownpending
245_024pure_playBiotech/LongevityColossal gene editing will reach thousands of edits (up from current hundreds)Ben Lamm34.2%unknownunknownpending
IND_005pure_playBiotech/LongevityConvergence of computational biology + AI-driven data modeling + CRISPR gene editing enables bringing back extinct species — Form Bio platform (spun out 2022) enables successful resurrection of woolly mammoth and Tasmanian tiger within the decade (by ~...Ben Lamm32.5%unknownunknownin_progress
245_003pure_playMarkets/StocksColossal's $10B valuation is massively undervaluedBen Lamm29.8%unknownunknownpending
IND_009pure_playBiotech/LongevityArtificial Superintelligence arrives by roughly 2030 — shortly thereafter all human illnesses will be cured 'much sooner than we think'; mechanism: AI not just predicting protein structures but generating novel biological designs revolutionizing drug d...Demis Hassabis18.9%unknownunknownpending
COD_BIO_005multi_vectorBiotech/LongevityColossal adds at least one more de-extinction species to active embryo-transfer pipeline by end 2028Codex Research Pack46.6%unknownunknownpending
COD_BIO_003multi_vectorBiotech/LongevityColossal completes mammoth embryo transfer into an elephant surrogate by end 2027Codex Research Pack19.5%unknownunknownpending
COD_BIO_004multi_vectorBiotech/LongevityColossal produces a live mammoth-like elephant calf by end 2028Codex Research Pack11.7%unknownunknownpending

Adverse scenarios (0)

Predictions where this ticker is displaced
PredDomainPredictionPredictorCurrentMoveImpactMechanism
No adverse scenarios